Skip to main content

Advertisement

Log in

Delayed onset Bickerstaff brainstem encephalitis overlapping Miller-Fisher Syndrome during SARS-CoV-2 infection

  • COVID-19
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Bickerstaff brainstem encephalitis (BBE) is a neuroimmunologic disease characterized by the acute onset of external ophthalmoplegia, ataxia, and consciousness disturbance, mostly subsequent to an infection. BBE is considered to be a variant of Miller-Fisher syndrome (MFS), which also exhibits external ophthalmoplegia and ataxia but not presenting consciousness alterations. Therefore, these two medical conditions are included in the clinical spectrum of the “Fisher-Bickerstaff syndrome” ( Shahrizaila and Yuki in J Neurol Neurosurg Psychiatry 84(5):576–583) [1]. With regard to the etiopathogenesis, increasing evidence worldwide suggests that SARS-CoV-2 infection-enhanced immune response is involved in a wide range of neurological complications such as Guillain-Barré syndrome (GBS), MFS, acute necrotizing encephalitis (ANE), myelitis, acute disseminated encephalomyelitis (ADEM), and, although very rarely, BBE either (Hosseini et al. in Rev Neurosci 32:671–691) [2]. We report a case of a patient affected by delayed onset BBE overlapping MFS during a mild SARS-CoV-2 infection. To the best of our knowledge, similar cases have never been reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

Data of the reported case is presented within the manuscript.

References

  1. Shahrizaila N, Yuki N (2013) Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 84(5):576–583. https://doi.org/10.1136/jnnp-2012-302824

  2. Hosseini N, Nadjafi S, Ashtary B (2021) Overview of COVID-19 and neurological complications. Rev Neurosci 32(6):671–691. https://doi.org/10.1515/revneuro-2020-0116

    Article  CAS  PubMed  Google Scholar 

  3. Krihara T, Igarashi Y, Kobai K, Mizobuchi T, Ishii H, Matsumoto N, Yokobori S, Yokota H (2020) Diagnosis and prediction of prognosis for Bickerstaff’s brainstem encephalitis using auditory brainstem response: a case report. Acute Med Surg. 7(1):e517. https://doi.org/10.1002/ams2.517

    Article  Google Scholar 

  4. Koga M (2013) Bickerstaff brainstem encephalitis: epidemiology, diagnosis, and therapy. Nihon Rinsho 71(5):898–903

    PubMed  Google Scholar 

  5. Odaka M, Yuki N, Hirata K (2001) Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 70:50–55

  6. Yoshikawa K, Kuwahara M, Morikawa M, Kusunoki S (2020) Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody. Neurol Neuroimmunol Neuroinflamm 7:e889. https://doi.org/10.1212/NXI.0000000000000889

    Article  PubMed  PubMed Central  Google Scholar 

  7. Guasp M, Muñoz-Sánchez G, Martínez-Hernández E, Santana D, Carbayo Á, Naranjo L, Bolós U, Framil M, Saiz A, Balasa M, Ruiz-García R, Sánchez-Valle R, Barcelona Neuro-COVID Study Group (2022) CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front Immunol 13:866153. https://doi.org/10.3389/fimmu.2022.866153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Imai T, Shimizu T, Hagiwara Y, Hirayama T, Hasegawa Y (2013) A case of Bickerstaff brainstem encephalitis successfully treated with intravenous immunoglobulin and methylprednisolone after unsuccessful immunoadsorption plasmapheresis. Open J Clin Diagn 3:1–4. https://doi.org/10.4236/ojcd.2013.31001

    Article  Google Scholar 

  9. Llorente Ayuso L, Torres Rubio P, Beijinho do Rosário RF, Giganto Arroyo ML, Sierra-Hidalgo F (2021) Bickerstaff encephalitis after COVID-19. J Neurol 268(6):2035-2037. https://doi.org/10.1007/s00415-020-10201-1

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Acampora.

Ethics declarations

Ethical approval and Informed consent

This study was conducted in accordance with the principles of the Declaration of Helsinki, and all patients provided written informed consent prior to enrollment.

Consent to participate

Written informed consent was obtained.

Conflict of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acampora, R., de Falco, A., Lanfranchi, F. et al. Delayed onset Bickerstaff brainstem encephalitis overlapping Miller-Fisher Syndrome during SARS-CoV-2 infection. Neurol Sci 44, 4179–4182 (2023). https://doi.org/10.1007/s10072-023-07142-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-07142-8

Keywords

Navigation